Scott Miller, Ph.D.

Dr. Miller is working with the Kopecek group on the development of nanotherapeutic
delivery systems for the treatment and/or imaging of skeletal diseases that include
osteoporosis, arthritis and cancer metastases to bone. Emphasis is placed on the development
of targeted biopolymers as imaging or therapeutic agents. They are also developing
amphipathic carrier systems to improve the pharmacokinetics and biodistribution of
chelators to remove toxic metals and radionuclides from the body. Imaging applications
of this technology are also being explored.